Napoleone Ferrara
Fondatore presso Theia Therapeutics, Inc.
Posizioni attive di Napoleone Ferrara
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of California | Corporate Officer/Principal | - | - |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Investitore di Private Equity | - | - |
| Theia Therapeutics, Inc. | Fondatore | - | - |
Gemini Pharmaceuticals, Inc.
 Gemini Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gemini Pharmaceuticals, Inc. manufactures pharmaceutical products. It offers dietary supplements, herbs and nutritional products. The firm's products include male and female libido enhancers, breast enhancers, smoking cessation supplements, weight loss supplements, multivitamins, digestive aids and painkillers towards pets. Gemini Pharmaceuticals was founded in 1982 and is headquartered in Commack, NY. | Consulente / Consigliere | - | - |
Inflammasome Therapeutics, Inc.
 Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Napoleone Ferrara
Precedenti posizioni note di Napoleone Ferrara
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
| KINTARA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 22/06/2018 | - |
| Independent Dir/Board Member | 22/06/2018 | - |
Formazione di Napoleone Ferrara
| University of Catania | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Italia | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KINTARA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
| Theia Therapeutics, Inc. | |
Gemini Pharmaceuticals, Inc.
Gemini Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gemini Pharmaceuticals, Inc. manufactures pharmaceutical products. It offers dietary supplements, herbs and nutritional products. The firm's products include male and female libido enhancers, breast enhancers, smoking cessation supplements, weight loss supplements, multivitamins, digestive aids and painkillers towards pets. Gemini Pharmaceuticals was founded in 1982 and is headquartered in Commack, NY. | Health Technology |
Inflammasome Therapeutics, Inc.
Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Health Technology |
- Borsa valori
- Insiders
- Napoleone Ferrara
- Esperienza
